Mediator is a key regulator of eukaryotic transcription 1 , connecting activators and repressors bound to regulatory DNA elements with RNA polymerase II 1-4 (Pol II). In the yeast Saccharomyces cerevisiae, Mediator comprises 25 subunits with a total mass of more than one megadalton (refs 5, 6) and is organized into three modules, called head, middle/arm and tail [7] [8] [9] . Our understanding of Mediator assembly and its role in regulating transcription has been impeded so far by limited structural information. Here we report the crystal structure of the essential Mediator head module (seven subunits, with a mass of 223 kilodaltons) at a resolution of 4.3 ångströms. Our structure reveals three distinct domains, with the integrity of the complex centred on a bundle of ten helices from five different head subunits. An intricate pattern of interactions within this helical bundle ensures the stable assembly of the head subunits and provides the binding sites for general transcription factors and Pol II. Our structural and functional data suggest that the head module juxtaposes transcription factor IIH and the carboxy-terminal domain of the largest subunit of Pol II, thereby facilitating phosphorylation of the carboxy-terminal domain of Pol II. Our results reveal architectural principles underlying the role of Mediator in the regulation of gene expression.
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In the yeast S. cerevisiae, the Mediator head module is composed of seven subunits 10 : Med17 (also known as Srb4), Med11, Med22 (Srb6), Med6, Med8, Med18 (Srb5) and Med20 (Srb2). Four subunits are encoded by SRB genes, first identified through a genetic screen for mutations suppressing the Pol II carboxy-terminal domain (CTD) truncation 11, 12 . The head module is essential for Mediator function because mutations in the head abolish messenger RNA synthesis in vivo 13, 14 and in vitro 15 , and eliminate Mediator interaction with promoters in vivo 10 . The head module is organized into three domains that can undergo significant conformational changes, and it interacts with the TATAbinding protein subunit of general transcription factor TFIID and the Rpb4 and Rpb7 subunits of Pol II (ref. 16 ). The head has also been shown to interact with TFIIH through the Med11 subunit 17 . Determining the architecture of the Mediator head module is therefore vital to understanding the mechanism by which Mediator controls gene expression.
We engineered the head module to obtain crystals of sufficient quality for structure determination ( Supplementary Information, section 1) . In our engineered Mediator head, Med18 loop regions and the aminoterminal 108 residues of Med17 were deleted, without apparent effect on the integrity of the complex (Supplementary Fig. 1 ). The modified head module was labelled with selenomethionine (SeMet) and purified as described previously 16 . By overcoming two major technical obstacles (Supplementary Information, section 2), we produced SeMet crystals that diffract to 4.3 Å (Supplementary Table 1 ). The electron density map was calculated to a resolution of 4.3 Å (Supplementary Fig. 2 ) by SeMet single anomalous dispersion (SAD) after initial phases had been obtained using Ta 6 Br 14 and K 3 Ir(NO 3 ) 6 derivatives ( Supplementary  Information, section 3 ).
We began identification of the individual polypeptide constituents of the Mediator head module by docking the Med18-Med20-Med8 C-terminal helix (CTH) complex structure 18 (Protein Data Bank ID, 2HZS) into the electron density map and then performing rigid-body refinement. The polypeptide chains of the other subunits were identified on the basis of the SeMet positions and their juxtaposition with large amino-acid side chains within ordered regions of secondary structure (Methods). This approach permitted the unambiguous assignment of all discernible elements of secondary structure in the density map to individual head module subunits ( Fig. 1 and Supplementary Figs 3-5).
Our crystal structure is consistent with the molecular envelope of the head module derived at a resolution of 30-35 Å by single-particle electron microscopy analysis ( Supplementary Figs 6 and 7) . The head can be described in terms of three major domains, a 'fixed jaw', a 'movable jaw' and a 'neck' (Fig. 1 and Supplementary Figs 4 and 5) , with a 'central joint' connecting these domains. Our X-ray structure of the head module reveals the overall architecture of the module and the domain boundaries. The domains are connected through flexible loops and linkers at the central joint.
Our previous work on expression and purification of the head module suggested that Med17 has a central role in head assembly 10 . The work we report here extends those results through a comprehensive biochemical analysis in combination with electron microscopy, to determine the Med17 domain structure and elucidate its interactions with other head components ( Supplementary Information, section 4) . The results support our model of the architecture of the head module.
Assembly of the head module starts with formation of the 'minihead' (Med17-Med11-Med22). Subsequently, Med8 and Med6 are added, followed by Med20-Med18 (ref. 10). Our structure shows that a four-helix bundle, built by a-helices from Med11 (BH1 and BH2) and Med22 (BH1 and BH2) interact with BH2 of Med17 to form the larger helical bundle (Figs 2 and 3 and Supplementary Fig. 4 ). This is consistent with the observation that omission of either Med11 or Med22 leads to disassembly of the head 10 . Med6 interacts with the mini-head through its BH1, and Med8 serves to stabilize the central a-helical bundle by surrounding the central helices. Finally, the Med18-Med20 heterodimer binds to the core-head, which is composed of five subunits (Med6, Med8, Med11, Med22 and Med17), primarily through the CTH of Med8 (Fig. 2) .
The fixed jaw domain comprises the CTHs of Med11 and Med22 and the CTD of Med17. The Med11 and Med22 CTHs interact with the helical regions of the Med17 CTD. Med17 (residues 610-660) forms a b-sheet structure that lines the inner surface of the fixed jaw and faces the movable jaw (Fig. 3a) . The Med17 CTD interacts with the loop region of Med18. The functional importance of the Med17 CTD correlates with the biochemical activity of the Head module in vitro, as well as phenotypic analysis in vivo, as loss of the Med17 CTD abolishes the transcription activity of the head module ( Supplementary Fig. 12 
LETTER RESEARCH
and all Med17 CTD deletion mutants as well as internal deletion mutants result in lethality ( Supplementary Fig. 13 ).
The movable jaw, so called because previous electron microscopy studies 16 demonstrated multiple orientations of this domain with respect to the rest of the head module, is formed by the Med18-Med20-Med8 CTH complex. As for the interaction with the Med8 CTH 18 , our complete head module structure has revealed additional interactions with the fixed jaw and neck domains. First, the Med18 loop region formed by residues 78-97 interacts with the Med17 CTH of the fixed jaw domain (Fig. 3a, b) . Second, the electron density corresponding to the N terminus of the Med11 subunit (residues 1-20) indicates an interaction with Med18 (residues 17-27 and 281-289; Fig. 3c, d ). The assignment of Med11 residues 1-20 was complicated by the substitution of Ser 17 for Met 17 (Methods), and an unambiguous sequence marker is therefore lacking. However, our biochemical data (Supplementary Information, section 5) support our architectural model, in which a stable association between Med18-Med20 and the head module requires binding to Med8 and at least one additional interaction (with Med11 or Med17). The interactions with the CTH of Med17 and the NTD of Med11 are likely to be critical for the functional positioning and flexibility of the movable jaw 16 ( Fig. 3b-d and Supplementary Fig. 6 ).
The neck domain has an unusual structure: a total of ten helices from five different subunits associate through the formation of a large helical bundle. The NTD of Med6 is located adjacent to the large helical bundle and consists of four a-helices (Figs 1b and 4a). The helical bundle of the neck domain can be divided into two parts, a short bundle composed of four short a-helices and a long bundle composed of six long a-helices. Three helices of the Med8 subunit (BH3, BH4 and BH5) seem to stabilize the assembly of both short and long bundles, and, thus, the entire neck domain structure. TATA-binding protein was reported to bind to the N-terminal 138 residues of Med8 (ref. 18) , which corresponds to helices BH1 to BH5, all of which are located on the surface of the neck domain.
The organization of the helical bundle in the neck domain may produce a relatively rigid structure that could mechanically convey regulatory signals. Several observations suggest that Med6 may function as an interface between the Mediator head and middle modules, and transduce a mechanical signal from the tail or middle to the head and onto Pol II ( Supplementary Information, section 6) .
Mediator stimulates the phosphorylation of Ser 5 in the Pol II CTD by TFIIH (ref. 19) , which promotes dissociation of Mediator from Pol II (refs 20, 21) , an important step in the transition from initiation to elongation of transcription 22 . Our structural and biochemical data, along with relevant previous observations 12, 17, 23, 24 , suggest an interaction of the Pol II CTD, the Mediator head module and TFIIH. First, mutation of Thr 47 to Ala in Med11 affects the interaction of TFIIH with the head module in vivo, resulting in a reduction of Pol II CTD Ser 5 phosphorylation 17 . Thr 47 of Med11 is located near the centre of the two symmetrical, long helical bundles of the neck, which thus could constitute the docking surface for TFIIH ( Fig. 4b and Supplementary Fig. 16c ). Second, three of four suppressor mutations of Pol II CTD truncation-Med17 (Gly 353 to Cys), Med22 (Asn 86 to Lys) and Med18 (Thr 22 to Ile)-map to the central joint region 12, 24 ( Supplementary Fig. 16a ), suggesting that there is a functional interaction between the CTD and this portion of the head, consistent with previous observations 23 . Third, the head module within the Mediator/ Pol II structure ( Fig. 4b and Supplementary Fig. 17 ) is located near the base of the CTD. Finally, our biochemical data show that the head module stimulates phosphorylation of the Pol II CTD by TFIIH (Supplementary Information, section 7, and Supplementary Fig. 18 ). Therefore, we suggest that the head module may function as a scaffold that juxtaposes TFIIH and the Pol II CTD, thereby facilitating CTD phosphorylation (Fig. 4b) . Our Mediator head structure reveals intricate interaction networks, notably the striking multi-helical bundle in the neck domain, engaging five Mediator subunits in a single structure unit. Such interactions could not have been determined from structures of individual subunits alone, nor from analysing pairwise small domaindomain interactions, but only by study of the multi-protein complex in its entirety.
METHODS SUMMARY
Structure determination. Modified head module was expressed with the MultiBac system 25 in insect cells and purified by nickel affinity chromatography. Crystals were obtained by the hanging-drop vapour diffusion method. The structure was determined by SeMet SAD after a sufficient number (98) of SeMet sites had been identified from a combination of initial phases obtained using Ta 6 Br 14 and iridium derivatives and partial-model SAD phases. Biochemical and electron microscopy analysis. The Mediator head and its mutants were expressed in insect cells and purified by nickel affinity chromatography. The electron microscope images of the head module and the mutants were collected and class averages were calculated. In vitro assays and yeast genetics. The in vitro transcription assay to assess activity of the recombinant head module and its mutant form using srb4 ts mutant crude extract, the assay for phosphorylation of the CTD of Pol II by TFIIH, and the yeast phenotypic analysis were all done as described previously 15 .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
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Construction of vectors.
All the vectors used in this study are summarized in Supplementary Tables 3 and 4 . For expression of the modified head module for crystallization, DNA sequences corresponding to residues 1-108 of Med17 were removed from vector pFL-10xHis-Med17 (ref. 16 ; pYT49) by the SLIC method 26 , yielding pFL-10xHis-Med17 (109-687) (pYT171). DNA sequences corresponding to residues 109-140 and 71-156 of Med18, respectively, were removed from vector pSPL-Med18-Med20 (ref. 16 ; pYT75), yielding pSPL-Med20-Med18 (D109-140) (pYT115) and pSPL-Med20-Med18 (D71-156) (pYT114). To eliminate an alternative translation start site, the Met (residue 17) of Med11 was mutated to Ser (pYT311). Finally, the transfer vector for the modified head module was generated by fusing three vectors, pYT171, pYT114 and pUCDM-Med6-Med22-Med11-Med8 (pYT120) by Cre/LoxP recombination as previously described 25 . DNA sequences corresponding to residues 1-16 of Med11 were removed from the vector pYT111 by SLIC, yielding the vector pUCDM-Med22-Med11 (D1-16) (pYT147). Fusion of pYT171, pYT147 and pYT120 with either pYT114 or, alternatively, pYT115 generated the expression vectors for a series of double Med18-Med11 partial head module deletion mutants.
The constructs for Med17 mutagenesis were generated as follows. BamHI and HindIII fragments corresponding to the C-terminal deletion mutants of Med17 were generated by first introducing a stop codon and a HindIII site (TAAAAGCTT) into pBacPAK9-10His-SRB4 (MED17) vector 10 adjacent to the sequences corresponding to residues 108, 200, 300, 400, 500 and 600 of Med17, by using the QuickChange mutagenesis kit (Stratagene), followed by BamHI and HindIII digestion and gel purification. The respective purified fragments were cloned into the BamHI and HindIII sites of pFL vector 25 , yielding vectors pYT165 to pYT170 (Supplementary Table 3 ). The N-terminal deletion, as well as the internal deletion mutant constructs of Med17, were generated by removing DNA sequences corresponding to residues 1-108, 1-201, 1-302, 1-400, 101-200, 201-300 and 301-400 from pFL-10xHis-Med17 by the SLIC method, yielding the respective vectors pYT183 to pYT186 and pYT289 to pYT291 (Supplementary Table 3 ). These vectors were fused with pUCDM-Med6-Med22-Med18-Med20-Med11-Med8 (pYT151), yielding vectors encoding for head modules comprising Med17 mutant forms. The vector pYT151 was created by two rounds of sequential cloning of PmeI and the AvrII fragments containing Med18-Med20 and Med22-Med11 into SpeI and NruI sites of pUCDM-Med6-Med8 (pYT110).
Introduction of the deletion mutations into the yeast shuttle vector pCT127, carrying the wild-type MED17 gene, was also carried out by SLIC. The yeast shuttle vectors used in this study are listed in Supplementary Table 4 . Expression and purification of the head module and mutants. Expression and purification of the recombinant head module, the mutant forms and the subcomplex was carried out in insect cells using the MultiBac system 25 . Production of hightiter viruses in Sf9 cells, and expression and purification of recombinant head modules of Mediator and its mutant forms was carried out as described previously 16 . Preparation of SeMet labelled Head module will be described elsewhere (T.I. et al., manuscript in preparation). Briefly, the insect cells were cultured in Met-free medium (Expression Systems) overnight before baculovirus infection. L-selenomethionine (20 mg l
21
; Sigma-Aldrich) was added at sequential 24-h intervals. Cells were collected 96 h after infection. SeMet-labelled complex was purified as described above. Limited proteolysis and identification of the peptide fragments. A total of 135 mg of the recombinant head module was incubated at 37 uC with chymotrypsin (Sigma-Aldrich) at a final concentration of 0.01 mg ml 21 in a volume of 150 ml in buffer A (20 mM Tris-HCl (pH 8.0), 100 mM NaCl and 1 mM DTT). Aliquots (20 ml) were taken at 0, 5, 10, 30 and 60 min, and 15 ml of PMSF stock solution (100 mg ml
) was added to stop the reaction by inhibiting the protease. Aliquots were applied to 12.5% SDS-PAGE and transferred onto a Sequi-Blot PVDF membrane (Bio-Rad). Protein bands were stained by Coomassie blue (R-250). Protein bands resulting from proteolysis during the time course were identified, excised and subjected to Edman degradation using a Procise 494 instrument from Applied Biosystems as previously described 27 . Stepwise-liberated PTH-amino acids were identified using an 'on-line' HPLC system (Applied Biosystems) equipped with a PTH C18 (2.1 3 220 mm; 5-mm particle size) column (Applied Biosystems). Crystallization and data collection. Crystals were obtained at 293 K by hangingdrop vapour diffusion against a reservoir solution of 0.1 M Tris-HCl (pH 7.6) containing 10-12.5% (w/v) PEG-6K and 0.4 M (NH 4 ) 2 SO 4 . Crystals were transferred into the reservoir solution containing 25% triethylene glycol (TEG). The crystals were flash-frozen for data collection at 100 K. SDS-PAGE analysis of the dissolved crystals confirmed the presence of all seven subunits. However, in situ proteolysis resulted in about 10% of the Med17 subunits being shortened at the N terminus by 76 residues and almost 100% of the Med6 subunits being shortened at the C terminus by 80 residues (Supplementary Fig. 1 ). Diffraction data were collected at beamline 23ID at the Advanced Photon Source (APS) at Argonne National Laboratory. All diffraction data were processed with HKL2000 28 . Twinning rates of the data sets were analysed using program PHENIX XTRIAGE 29 . Structure determination of the Mediator head module. Initial phases were determined by two approaches: Ta 6 Br 14 single isomorphous replacement with anomalous scattering (SIRAS) and iridium single anomalous dispersion (SAD). Ta 6 Br 14 derivative crystals were prepared by soaking the native head module crystals in reservoir solution containing 1 mM Ta 6 Br 14 . The initial phase was determined by SIRAS at a resolution of 7.5 Å . Density modification using the program PARROT extended the phase resolution to 4.3 Å using the SeMet data set. Iridium derivatives of the crystal of Mediator head module were prepared by soaking the crystals in crystallization reservoir solution containing 10 mM K 3 Ir(NO 3 ) 6 . The initial iridium phase was obtained by SAD using the programs SHELXD and PHASER 30, 31 . The phase was extended followed by density modification by program PARROT 32 with the SeMet data set. However, the maps obtained at this stage were not yet interpretable.
To improve the maps, we used them together and applied the following methods: (i) location of SeMet sites in the crystal; (ii) non-crystallographic symmetry (NCS), averaging between three molecules in the NCS using the program DM 33 ; (iii) partial model building into the clearly discernible rod-like electron density from a-helices, followed by rigid-body refinement using the programs COOT and REFMAC5 34 ; and (iv) re-calculating phases by SeMet SAD phasing with PHASER, using the partial model and SeMet positions. Iterative rounds combining these procedures were performed until the model covered all interpretable secondary structure elements. Eventually, we could identify 98 SeMet sites. To minimize model bias, phases were re-calculated by SeMet SAD with PHASER, using only the positions of these 98 selenium sites, and these improved SAD phases guided the final modelbuilding steps.
Model building and refinement. Assignment of polypeptide identities was carried out as follows. The published structure 18 of Med18-Med20-Med8 (CTH) (PDB ID, 2HZS) was manually docked into the electron density map, followed by rigid-body refinement by using COOT. Then the a-helices for the further polypeptides of the head module were manually built, and connected. Next, b-sheets were manually built into the unassigned structured regions in the electron density, which corresponded to the neck and fixed jaw domains. Subsequently, we began assigning the polypeptide identities at the neck domain. We tracked specific SeMet labelling patterns dictated by the presence of Met in the primary sequences of the polypeptides, and the presence of bulky regions corresponding to aromatic residue positions, as markers. We used secondary structure predictions for additional guidance. First, Med8 BH1, Med17 BH1 and Med22 BH2 were identified in a-helical bundle regions in the neck domain from their primary-sequence-specific, unique SeMet labelling pattern: these regions all contain more than two SeMet peaks and the spacing of SeMet peaks was consistent with the corresponding amino-acid sequences in the subunits. This assignment was consistent with the secondary structure predictions indicating a-helical structure. The remaining Med8 residues (60-170), as well as Med22 BH1, were assigned by tracing from the Med8 BH1 helix back to the Med8 C terminus, and by tracing from the Med22 BH2 helix back to the Med22 N terminus. This assignment was validated by the fact that their Met locations aligned with anomalous peaks on the experimental map. Next, we identified the NTD of Med6 based on its unique SeMet positions, and also identified Med6 BH based on a specific location of SeMet (Met 48), a bulky aromatic ring (Phe 52) ( Supplementary Fig. 19a ) and continuity from the NTD of Med6, consistent with secondary structure predictions. The C-terminal 80 residues of Med6 were proteolyzed in the crystals (Supplementary Fig. 1 ). Consequently, no density was found corresponding to the C terminus of Med6. We traced Med17 BH1, and identified the longest helix in the neck domain as the BH2 helix of Med17 on the basis of a single SeMet (Met 313) and the aromatic side chain of Tyr 269 ( Supplementary Fig.  19b) ; this assignment was also consistent with secondary structure predictions. Finally, the two remaining continuous a-helices in the neck domain were identified as Med11 BH1 and Med11 BH2 because of one unique SeMet position of Med11. This assignment matches perfectly to the secondary structure prediction as well.
Next we focused on the fixed jaw domain. By subtracting the polypeptides already assigned to the neck and the movable jaw (see above), the fixed jaw should only contain the C-terminal regions of subunits Med11, Med17 and Med22. First, on the basis of continuity, SeMet position (Met 422), aromatic ring position (Tyr 423) ( Supplementary Fig. 19c ), and secondary structure prediction, we identified helix 420-455, b-sheet 456-480 and helices 496-523 and 540-570 of Med17. The remainder of the electron density in this region was continuous, and thus enabled us to trace Med17 completely to its C terminus. We identified the Med17 CTH and b-sheet with a-helix 600-608 on the basis of the SeMet positions and a-helix length from secondary structure prediction. Finally, we assigned two remaining helices: Med11 CTH was identified from the presence of one SeMet peak, and we assigned the last helix to Med22 CTH, which entirely lacks SeMet.
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Initially, all models were refined using the program CNS DEN 35 , refinement with strong NCS restraints between the three independent complexes in the asymmetric unit, and twinning refinement. Then the model was refined using PHENIX with NCS restraints and a single refined group isotropic temperature factor for each subunit, Ramachandran restraint, TLS refinement and twinning refinement. The geometry of the final model is good, with 91.3%, 8.0%, 0.7% of the amino-acid residues in the most favoured, allowed, and disallowed regions of the Ramachandran plot, respectively. All structural illustrations and electron density maps were prepared with PYMOL (http://www.pymol.org/) and COOT. PSIPRED was used for secondary structure prediction 36 . Docking of the X-ray structure into the electron microscopy map. The model of 12-subunit Pol II was docked into the Mediator-Pol II holoenzyme structure 8 followed by docking of the X-ray model of the head module into the density corresponding to the Mediator head module, using the program CHIMERA 37 .
Electron microscopy sample preparation, data collection and image analysis. We diluted purified head module deletion mutants in buffer containing 25 mM KCl, 25 mM Tris-HCl (pH 7.8) and 5 mM DTT. For preparation of all electron microscopy samples, about 3 ml of protein solution was applied to a carbon-coated Maxtaform, 300-mesh Cu/Rh EM specimen grid (Ted Pella) freshly glowdischarged in the presence of amyl amine. The particles were then preserved by staining with a 2.0% (w/w) uranyl acetate solution using the sandwich carbon layer technique 38, 39 . The images were recorded under low-dose conditions using a Tecnai Spirit (Philips/FEI) microscope equipped with a LaB6 filament and operating at an accelerating voltage of 120 kV. Images were recorded on a Tietz (TVIPS) CCD camera at 342,000 magnification and approximately 1-mm underfocus, resulting in a final pixel size corresponding to 5.06 Å .
The images were initially analysed using the ml_align2d program, a multireference, two-dimensional alignment routine with a maximum-likelihood target function 40 implemented in the XMIPP package 41 . Averages derived from the ml_align2d program were used to run iterative alternating rounds of supervised multi-reference alignment/classification and reference-free alignment as described previously 42 to improve the homogeneity of the image classes. In vitro transcription and the CTD phosphorylation assays. The in vitro transcription assay to assess activity of the recombinant head module and its mutant form using srb4 ts mutant crude extract was performed as described previously 10 . Quantification of transcripts on an absolute scale was performed using a FLA-5100 FUJIFILM fluorescent image analyser and the MultiGauge software package after addition of 1 nCi of -32 P UTP to the gel 5 min before the end of the run. The CTD phosphorylation assay was performed as previously described 15 . Yeast phenotypic analysis. The shuttle vectors carrying the MED17 mutations are described in Supplementary Table 4 . The shuttle vectors were introduced into yeast strain Z572 by plasmid shuffling, and grown on SC medium containing 5-FOA at 30 uC as previously described 15 .
